bluebird bio Inc at Bank of America Global Healthcare Conference (Virtual) Transcript
Good day, everybody. My name is Jason Gerberry. I'm one of the biotech analysts of Bank of America. It's my pleasure to be introducing our next company presenter at the Bank of America Healthcare Conference. We are joined by bluebird bio. And we've got the future management team of the genetic disease -- what will be the future genetic disease company.
So for those of you not familiar, bluebird bio will be splitting its oncology and genetic disease businesses sometime in the fourth quarter. So when that change occurs, we've got the management team with us. We've got Andrew Obenshain, who is going to be CEO; Richard Colvin, CMO; and Tom Klima will be Chief Commercial Officer. So I guess first off, gentlemen, thanks so much for joining us in advance of this momentous event for the Company.
Thank you.
Questions & Answers
So I think a
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
